Over the past five years, the cosmetic industry has met with several legislative changes. Within the new legislative package, including the new REACH and CLP, it is important to find a comfortable routine that will minimize costs while staying effective and compliant with all regulations.
Interview with Marina Lavrova
Read the short interview with Marina Lavrova, Quality director, Sphera - Pharm, Russia.
As you are going to speak about the changes that you have implemented recently in your company, can you reveal what were the reasons for those changes?
All companies go through the changes – planned or unplanned. We understand that the change management system requires agreed decisions and integration with quality risk management processes.
Implementation of computer systems for managing changes provides with benefits such as:
- Absolute transparency of change management process
- Reduction of the amount of time needed for change implementation
- Risk-oriented approach to change management
- Decreasing the amount of mistakes
- Exclusion of hard copies
...and – as conclusion – reduction of the overall costs for managing poor quality of a product.
Interview was made for the 1st annual of the Quality Assurance in Russian Pharma Manufacturing conference which took place on 27-28 of May 2015 in Moscow, Russia.
Find out more about the upcoming event:
Interested in this topic?
Advanced Protein Aggregation & Characterization
This training will focus on occurrence of particles in drug products, effects of protein aggregates, critical process and parameters. Attendees will gain overview of on utility and limits of predictive experiments, learn concerns from the authorities and relevant aggregation guidelines, and more.
CMC Analytical Comparability: Methods & Strategies for Biologics, Biosimilars & Biobetters
Attendees will be introduced to comparability in biosimilar development, the analytical strategies of protein characterization of biosimilars, the structure of proteins, in vitro pharmacology and much more.
Corporate Compliance & Transparency in the Pharmaceutical Industry
This two-day conference will serve as a platform for an open and dynamic dialogue with HCPs and patients to achieve common goals. Learn how to embed compliance in the business and develop one simple system for managing compliance & transparency in a complex and regulated environment.
Dr. Asma Ibrahim Al Mannaei, Director, Healthcare Quality Division | HAAD
Strategize your Risk Management Plan in 2 steps
Read below the interview with Judy to reveal the latest trends in risk management and find out what are the most important steps towards strategizing your risk management plan.
A prescription of Quality and Efficiency in the right doses
Read below the interview with Ronan to understand the importance of balance between quality and efficiency and reveal which pitfalls to avoid.